New triple therapy shows promise in shrinking advanced stomach tumors before surgery
Disease control
Recruiting now
This study tests whether adding an immunotherapy drug (anti-PD-1) and an immune booster (thymalfasin) to standard chemotherapy (SOX) before surgery can help people with stage III stomach or gastroesophageal junction cancer. About 30 adults aged 18-75 will receive the combination,…
Phase: PHASE2 • Sponsor: Zekuan Xu • Aim: Disease control
Last updated May 15, 2026 11:53 UTC